Myeloma Investment Fund (MIF)
Invests in early stage myeloma biotech companies through venture philanthropy capital.
About
The Multiple Myeloma Research Foundation's Myeloma Investment Fund is its venture-philanthropy arm, built as a wholly owned subsidiary rather than a grant program. It backs early-stage biotech companies developing myeloma therapies and technologies, and it sits inside MMRF's broader mission to accelerate better treatment and longer survival for patients.
The fund has committed $23 million since i…
BiotechMedtech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.